Alzheimer's disease research, amyloid plaques, tau tangles, and cognitive decline
416 articles
New brain imaging study identifies specific neurotransmitter pathways that make certain brain regions more vulnerable to Alzheimer's disease.
New AI model using blood tests better predicts brain aging and amyloid buildup linked to dementia risk.
New research reveals how brain immune cells respond to vascular damage, offering clues for early Alzheimer's intervention strategies.
Influential study on brain protein effects withdrawn, highlighting ongoing challenges in dementia research reliability.
Donanemab treatment effectively removed amyloid plaques from a female Alzheimer's patient's brain, offering hope for disease progression.
Researchers developed G-ALPS, an improved brain imaging tool that more accurately tracks cognitive decline and aging.
New research reveals that 32% of early Alzheimer's patients also have alpha-synuclein protein aggregates, linked to smell loss.
Revolutionary Wave-CAIPI technology dramatically reduces brain scan time while maintaining accuracy for monitoring Alzheimer's treatments.
New research reveals Alzheimer's heritability ranges from 29% to 78% depending on ancestry, with major implications for personalized prevention.
Following Mediterranean or MIND diets for decades significantly reduced dementia risk and slowed cognitive aging in 130,000+ adults.
New molecular mapping technique identifies individuals uniquely and predicts cognitive decline more accurately than standard brain scans.
Researchers tracked brain blood flow in 12,000+ people, revealing progressive decline that predicts cognitive deterioration.
